CoChat

Protection with estradiol in developmental models of apoptotic neurodegeneration

Asimiadou, Stiliani, Bittigau, Petra, Felderhoff‐Mueser, Ursula, Manthey, Daniela, Sifringer, Marco, Pesditschek, Stefanie, Dzietko, Mark, Kaindl, Angela M., Pytel, Maria, Studniarczyk, Dorota, Mozrzymas, Jerzy W., Ikonomidou, Chrysanthy · 2005 · Annals of Neurology
Cited by 77

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Medical measures that bear no known danger for the adult brain may trigger active neuronal death in the developing brain. Pharmacological blockade of N‐methyl‐D‐aspartate or activation of GABA A receptors, blockade of voltage‐dependent sodium channels, and oxygen induce widespread apoptotic neurodegeneration during the period of rapid brain growth in rodents. Because such measures are often necessary in critically ill infants and toddlers, search for adjunctive neuroprotective strategies is warranted. We report that 17β‐estradiol ameliorates neurotoxicity of drugs that block N‐methyl‐D‐aspartate receptors, activate GABA A receptors, or block voltage‐gated sodium channels and reduces neurotoxicity of oxygen in the infant rat brain. This neuroprotective effect is reversed by tamoxifen and cannot be reproduced by 17α‐estradiol. 17β‐Estradiol did not affect GABA A or N‐methyl‐D‐aspartate currents in hippocampal neuronal cultures, indicating that direct modulation of neurotransmitter receptor/channel properties by this compound cannot explain neuroprotective effect. 17β‐Estradiol did, however, increase levels of phosphorylated extracellular signal‐regulated kinase 1/2 and AKT, suggesting that activation of these prosurvival proteins may represent one mechanism for its neuroprotective action. 17β‐Estradiol and related compounds may be neuroprotective agents suitable for use in critically ill infants and toddlers. Its supplementation may particularly help to improve neurocognitive outcome in preterm infants who are prematurely deprived of maternal estrogen. Ann Neurol 2005;58:266–276

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.20553

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 77

Metadata

Authors
Asimiadou, S., Bittigau, P., Felderhoff‐Mueser, U., Manthey, D., Sifringer, M., Pesditschek, S., Dzietko, M., Kaindl, A. M., Pytel, M., Studniarczyk, D., Mozrzymas, J. W., & Ikonomidou, C.
Venue
Annals of Neurology
Publisher
Wiley
Published
2005-07-27
Volume
58
Issue
2
Pages
266-276
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2089603209
Cited by
77
References
10
FWCI
4.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection with estradiol in developmental models of apoptotic neurodegeneration. https://app.cochat.ai/papers/10.1002/ana.20553
The paper
Asimiadou, S., Bittigau, P., Felderhoff‐Mueser, U., Manthey, D., Sifringer, M., Pesditschek, S., Dzietko, M., Kaindl, A. M., Pytel, M., Studniarczyk, D., Mozrzymas, J. W., & Ikonomidou, C. (2005). Protection with estradiol in developmental models of apoptotic neurodegeneration. Annals of Neurology. https://doi.org/10.1002/ana.20553

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.